Navigation Links
Macugen drug for treating degenerative eye disease

The drug Macugen is found to be effective in treating wet age related macular degeneration disease which is a progressive disease// of the macula. Wet age related macular degeneration is caused due to a chronic degenerative disease of the macula region of the eye, macula is present in the retina which is responsible for proper eye sight.

The degenerative disease is caused by the growth of abnormal blood vessel beneath the macula which leads to severe bleeding and accumulation of fluid in retina leading to a condition called Choroidal neovascularization. The new drug Macugen, which is manufactured by Pfizer and OSI Pharmaceuticals, is found to be very effective in treating this degenerative disease by preserving the visual integrity of the macula, the drug is found to stop bleeding and accumulation of fluid in the retina and is found to be very effective than other treatment procedures offered to cure eye disease.


'"/>




Page: 1

Related medicine news :

1. Eye Drug Macugen Shows Allergic Reactions
2. Gene Therapy shows promise in treating Hemophilia
3. Ketoconazole 2% more effective in treating Seborrheic Dermatitis
4. Diuretics are better for treating blood pressure problems than newer medicines
5. A ray of hope in treating blindness and other eye disorders
6. Child Friendly Zidovudine Preparation for treating HIV infection Approved By The FDA
7. Surgeons in India to Mend ‘Pakistani Hearts’ by treating 70 Childrn
8. Weight reduction by 5% may help in treating nonalcoholic fatty liver disease
9. Lower doses of oral contraceptives helpful in treating acne
10. Systemic Corticosteroid Therapy can be used for treating all types of Infectious Mononucleosis
11. Novel Actemra monotherapy in treating patients with early aggressive rheumatoid arthritis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... 2017 , ... Many families have long-term insurance that covers care for a ... waiver for care if the client has a cognitive impairment diagnosis. , “What ... is often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... viewers the lowdown on sciatica in a new episode of "Success Files," which ... current events and innovation and investigates each subject in-depth with passion and integrity. ...
(Date:10/12/2017)... ... 12, 2017 , ... CitiDent and San Francisco dentists, Dr. ... Oventus O2Vent technology. As many as 18 million Americans are estimated to suffer ... Oral appliances can offer significant relief to about 75 percent of people with ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a ... health care, have expanded their existing home health joint venture through an agreement, ... been operating a joint venture home health company with Asante, delivering clinically integrated ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the ... – Miles by Moonlight to raise money for the American Heart Association Heart Walk. ... , Teams will work together to keep their treadmills moving for 5 hours. Treadmills ...
Breaking Medicine News(10 mins):
(Date:9/18/2017)... , Sept. 18, 2017 ... fields of bioinformatics and immune engineering, today ... protective avian influenza A (H7N9) vaccine. ... related to seasonal influenza and presents a ... on prior exposure to be effective. Using ...
(Date:9/12/2017)... NEW YORK , Sept. 12, 2017   EcoVadis , ... supply chains, has published the first annual edition of its Global CSR ... than 20,400 companies evaluated by EcoVadis, based on Scorecard Ratings that analyzed ... ... & Performance Index ...
(Date:9/12/2017)... , Sept. 12, 2017  ValGenesis Inc., the ... (VLMS), is pleased to announce the appointment of ... of its Board of Directors and Chairman of ... enables life science companies to manage their entire ... of paper in this process. Furthermore, ValGenesis VLMS ...
Breaking Medicine Technology: